Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
The study is a double-blind, randomized, placebo-controlled, multi-center, Phase 3 study to evaluate the efficacy and safety of fostamatinib in COVID-19 subjects.
Epistemonikos ID: 401149678f41bc4f87c4588b74b9659569f5218a
First added on: Nov 17, 2020